Account
Insider Insights
15.08.2024
Significant update in US drug pricing: Medicare to...

The Biden administration’s recent drug price negotiations under the Inflation Reduction Act re...

Read more
Articles
24.01.2024
What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Insider Insights
24.07.2023
Johnson & Johnson sue the US government

J&J sues US government, alleging infringement on First Amendment rights and unfair drug pricing unde...

Read more
Insider Insights
12.06.2023
CMS sets inflation penalties on 43 drugs

In a move towards curbing rising drug prices, the Inflation Reduction Act (IRA) provision will impos...

Read more
Publications
09.05.2023
ISPOR US 2023: Plenary Session 1 – Global Fo...

Our experts provide a detailed summary of Plenary Session 1 at ISPOR Annual 2023 on global affordabi...

Read more
Articles
11.01.2023
What are the 5 Pricing & Market Access trends ...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Insider Insights
23.08.2022
Inflation reduction act aims to reduce healthcare

The legislation is an updated, smaller version of The Build Back Better Act (BBBA) which the US Sena...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch